|
Market Closed -
NSE India S.E.
11:05:08 26/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 2,225.80 INR | +2.73% |
|
-0.04% | +9.37% |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 09-07 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.73% | -0.04% | -6.48% | +1.54% | +9.37% | +22.38% | +196.46% | +358.03% | +138.41% | 6.44B | |
| +0.58% | +3.22% | +8.06% | +6.91% | +19.13% | +54.92% | +125.36% | +415.33% | +1,567.90% | 1,135B | |
| +0.64% | +4.51% | -2.47% | -0.27% | +28.16% | +39.38% | +78.01% | +60.02% | +131.52% | 635B | |
| +0.20% | +1.12% | +7.34% | +11.26% | +25.10% | +25.35% | +96.86% | +161.06% | +368.43% | 505B | |
| +1.43% | +4.31% | +11.56% | +10.11% | +20.81% | +48.28% | +67.12% | +10.77% | +75.06% | 378B | |
| -3.03% | -1.97% | -5.30% | +7.68% | +33.77% | +60.01% | +33.40% | +71.19% | +131.32% | 358B | |
| -0.41% | +2.64% | +5.01% | -0.81% | +16.31% | +23.58% | +49.82% | +63.71% | +79.04% | 295B | |
| +0.23% | +3.66% | +2.90% | -0.26% | -6.79% | +2.45% | +23.69% | +42.77% | +169.08% | 266B | |
| +0.44% | +3.74% | +5.43% | +17.16% | +34.68% | +51.40% | +63.44% | +111.24% | +177.27% | 237B | |
| +1.50% | +3.21% | +3.80% | +21.05% | +28.72% | +31.14% | +101.26% | +133.26% | +109.59% | 193B | |
| +0.12% | +1.54% | +3.25% | -20.23% | -19.92% | -23.40% | -61.50% | -24.02% | +89.42% | 172B | |
| -0.85% | +0.97% | +3.50% | +20.49% | +19.38% | +20.00% | -4.61% | -31.76% | -8.26% | 171B | |
| -1.84% | +2.20% | -2.78% | +7.10% | +13.15% | +22.09% | +41.99% | +178.69% | +551.75% | 133B | |
| -0.28% | +4.06% | -4.16% | -2.14% | +13.50% | +41.09% | +15.57% | +5.12% | +24.20% | 126B | |
| -1.04% | -1.90% | +15.76% | +16.61% | +20.84% | +22.16% | +119.47% | +376.62% | +525.10% | 117B | |
| +1.11% | +3.23% | +2.96% | -2.35% | +4.96% | +16.77% | +29.88% | +6.82% | -5.81% | 102B | |
| +0.62% | +5.03% | +3.58% | -4.13% | -9.84% | -15.38% | -25.76% | -12.92% | +9.50% | 99.44B | |
| -0.31% | +2.44% | +6.50% | +20.08% | +3.79% | +36.87% | +1.15% | +35.29% | +120.65% | 80.39B | |
| -0.06% | -13.09% | -0.05% | +254.45% | +568.63% | +639.61% | +159.52% | -42.97% | - | 79.89B | |
| +1.50% | +8.56% | +4.25% | -7.00% | -16.33% | -0.55% | +56.47% | +62.44% | +479.58% | 71.3B | |
| Average | +0.18% | +1.30% | +3.13% | +17.86% | +40.37% | +55.91% | +58.38% | +99.03% | +249.14% | 258.06B | |
| Weighted average by Cap. | +0.14% | +1.59% | +4.18% | +9.92% | +26.92% | +44.60% | +70.22% | +148.63% | +482.75% |
- Stock Market
- Stocks
- GLENMARK Stock
- Sector Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
